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ABSTRACT
Syphilis is a chronic bacterial sexually transmitted infectious disease caused by 
Treponema pallidum. Different age groups are affected by heterogeneous clinical forms 
of the disease. We report a case of atypical secondary syphilis in an elderly patient with 
diffuse annular erythematous lesions on the chest, back, upper and lower limbs diagnosed 
by histopathological, immunohistochemical and serological tests.
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INTRODUCTION
Syphilis is a sexually transmitted infection caused by Treponema pallidum, a 
spiral-shaped bacterium that belongs to the Class Spirochaetes. During the 2000s, 
cases of syphilis were mostly reported in homosexual and HIV-infected patients. 
The Center for Diseases Control and Prevention (CDC) in the United States reported 
an increase of 80% in the number of cases between 2014 and 20181. 
The diagnosis of syphilis can be a challenge even for the most experienced 
dermatologist due to several clinical forms and a number of differential diagnoses 
that must be excluded. The disease’s natural history evolved with alternating periods 
of activity and different clinical, immunological characteristics (primary, secondary 
and tertiary) and latency periods. Primary syphilis is characterized by a solitary, 
ulcerated, painless lesion with a hardened edge and an inside portion of the lesion 
clean. Lesions appear on average three weeks after the infection and disappear in 
3-8 weeks, regardless of treatment2,3.
Secondary syphilis occurs between 6 to 8 weeks after the primary lesion. 
Syphilitic roseola is the first manifestation, characterized by erythematous, lenticular, 
oval or circular, isolated or confluent lesions. These lesions are highly variable and 
may vary from fine, slightly scaly papules to exophytic verrucous forms, mainly 
affecting the trunk and thighs. Erythematous lesions with a flat surface and striking 
collar scales can affect the palms and feet soles2. Nodular variants of secondary 
syphilis can present as erythematous, violaceous plaques, or nodules3. 
The morphology of secondary annular syphilis varies from fine, slightly scaly 
papules to exophytic verrucous forms that can affect the scalp, trunk, perioral, 
perianal and genital regions. They may be accompanied by non-specific symptoms 
(fever, malaise, headache, odynophagia) in 12% of patients. Iritis, anterior uveitis, 
osteitis, periostitis, glomerulonephritis, hepatitis and nephrotic syndrome are 
secondary syphilis manifestations3. Painless generalized adenopathies are present in 
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up to 70 to 85% of patients. Due to the variety of secondary 
presentation forms, it is essential to pay attention to the 
different diagnoses, such as pharmacodermia, viral rash, 
pityriasis rosea, figured erythema and leprosy2,4.
Tertiary syphilis occurs in approximately 15% to 25% 
of untreated infections. It can appear between 1-40 years 
after the onset of the infection1. It is characterized by the 
involvement of the nervous system, cardiovascular system, 
and the formation of the syphilitic gumma, a proliferative 
granulomatous process that can affect any tissue in the body.
In the reported case, the patient had diffuse erythematous 
annular lesions characterizing an atypical secondary syphilis.
CASE REPORT
The patient was a male, caucasian, 86 years old patient. 
He reported to be a retired military, heterosexual, widowed, 
with a previous history of hypertension and a of sexual 
intercourses with a prostitute. On admission, he presented 
diffuse spots on his body that appeared three weeks before 
his first evaluation at a dermatology clinic in Santa Cruz do 
Sul, Rio Grande do Sul State, Brazil. Later, he was admitted 
to the Hospital Santa Casa de Misericordia in Porto Alegre, 
Rio Grande do Sul State, Brazil , two months after the onset 
of the first lesion (day 0). When he arrived, he did not present 
the typical primary syphilis lesions, and denied other skin 
lesions preceding the current condition. However, he had 
mild symptoms of fatigue and joint pain. He also reported 
a weight loss of 10 kg in the last two months without a 
calorie-restricted diet. During the physical examination, we 
found diffuse annular erythematous plaques on the chest, 
back, upper and lower limbs (Figure 1). No palpable lymph 
node enlargement or other changes were identified in the 
physical examination. 
When he arrived at the hospital, he no longer had the 
typical primary syphilis lesions. Serology and a biopsy of 
an anterior chest lesion were requested. The VDRL test 
found a ½ titer, and the anti-Treponema pallidum IgM 
antibody was positive. The serological assessment for 
HIV, hepatitis B, and hepatitis C was negative (day  5). 
The histopathological examination showed a dense 
mononuclear infiltrate in the epidermis and hypodermis, 
with perivascular and perianexial involvement (day 14) 
(Figure 2). The immunohistochemistry showed the presence 
of anti-treponemal antibodies and numerous spirochetes 
(Figure 3). The clinical protocol and therapeutic guidelines 
for sexually transmitted infections5 recommend the use of 
benzathine benzylpenicillin 2.4 million international units 
(IU), intramuscularly (IM), in a single-dose (1.2 million in 
each gluteus). However, most treated cases report a better 
outcome with the administration of three doses6,7. The 
dermatologist, in this case, chose to treat the suggestive 
secondary syphilis with benzathine penicillin and a total 
Figure 1 - Annular erythematous plaques with spared centers 
on the chest and upper limb.
Figure 2 - A histopathological exam showing a perivascular 
lymphoplasmacytic infiltrate (HE, 40X).
Figure 3 - Anti-treponemal antibodies and spirochetes in an 
immunohistochemistry test (40X, indicated by the arrows).
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dose of 4,800,000 IU as a precaution. The first dose on the 
first day of treatment was 2,400,000 IU; on day seven, the 
patient received a second dose of 1,200,000 IU; and on day 
14, the third dose of 1,200,000 IU. The lesions disappeared 
in 30 days.
DISCUSSION
Currently, the treatment of syphilis can be troublesome. 
The disease can have different forms of lesions and 
difficult-to interpret laboratory results8. Patients with 
secondary syphilis usually have one or more systemic 
symptoms associated with a positive serology. Tertiary 
syphilis, on the other hand, usually occurs decades after 
the primary infection and includes aortitis, gum lesions, 
dementia and tabes dorsalis in people with positive 
serology8,9.
Non-treponemal tests include the rapid plasma reagin 
(RPR) and the Venereal Disease Research Laboratory 
(VDRL). The results of these tests are expressed in titles, 
indicating the last dilution of the sample that still shows 
reactivity or visible flocculation. These two tests are 
not equivalent and can vary according to the laboratory. 
Treponemal tests measure specific IgM and IgG antibodies 
against T. pallidum proteins, including the T. pallidum 
particle agglutination (TPPA), the Fluorescent Treponemal 
Antibody Absortion Test (FTA-ABS), and the treponemal 
pallidum hemagglutination assay by [TPHA], and 
more recently, the enzyme immunoassay (EIA) and the 
chemiluminescent immunoassay [CLIA]10. Furthermore, 
different factors can interfere with the evolution of 
serological markers, such as age, sex, stage of syphilis at 
the time of diagnosis11. False-positive results of VDRL 
generally show titers below ⅛. However, values like ½ 
can be found in patients with true syphilis. False-positive 
VDRL can occur due to several different health conditions, 
particularly in older people. The elderly patients can 
present with rheumatoid factor, antinuclear antibodies and 
hypergammaglobulinemia. These findings corroborate 
the importance of combining different diagnostic tests9,12. 
Although serological methods are the main tools to confirm 
the diagnosis of secondary syphilis, skin biopsies are often 
performed to control possible false positive and negative 
results13. In the case reported here the anti-T. Pallidum 
IgM can be considered low, however, the detection of IgM 
antibodies is important in the differentiation between late 
(tertiary) and recent infection (primary and secondary)14. 
It is known that after treatment of primary and secondary 
syphilis, IgM antibodies against T. pallidum become 
undetectable within 6-12 months15. Our patient did 
not report antibiotic therapy in the months before the 
hospital admission, so we could not confirm that the low 
IgM title was due to previous medication. However, his 
clinical conditions were not compatible with late/tertiary 
syphilis. Based on the clinical findings, the time elapsed 
since the appearance of the skin lesions until he sought 
medical attention, and the results of the exams, a case of 
secondary syphilis was suggested even if the presentation 
was uncommon for a secondary syphilis. Usually, in 
secondary syphilis the cutaneous rash is diffuse, symmetric, 
erythematous and annulopapular16.
The increase in life expectancy, in the quality of life, 
and the availability of medication that allows a prolonged 
sexual life have caused changes in the sexual behavior of the 
elderly, making this age group more vulnerable to sexually 
transmitted infections, such as syphilis17. 
CONCLUSION
An important factor change in the characteristics of 
patients with syphilis is the growth of this infection among 
the elderly. The diagnosis of patients with manifestations of 
disseminated annular erythematous lesions can be difficult 
due to the variety of differential diagnoses and the criteria 
to define risk groups. Syphilis in the elderly population 
has increased in recent years, requiring a more careful 
observation by dermatologists.
AUTHORS’ CONTRIBUTIONS
DMP, MLS: article writing and revision; FBP, NABS, 
GKR: the patient’s diagnosis; ILS, LL: the pathological 






 1.  Ghanem KG, Ram S, Rice PA. The modern epidemic of syphilis. 
N Engl J Med. 2020;382:845-54.
 2.  Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. 
Departamento de Doenças de Condições Crônicas e Infecções 
Sexualmente Transmissíveis. Protocolo clínico e diretrizes 
terapêuticas para atenção integral às pessoas com infecções 
sexualmente transmissíveis (IST). Brasília: Ministério da 
Saúde; 2020. 
Pagani et al.
Rev Inst Med Trop São Paulo. 2021;63:e68Page 4 of 4
 3.  Ivars Lleó M, Clavo Escribano P, Menéndez Prieto B. Atypical 
cutaneous manifestations in syphilis. Actas Dermosifiliogr. 
2016;107:275-83.
 4.  Bonamigo RR, Dornelles SI, editors. Dermatology in public 
health environments: a comprehensive textbook. Switzerland: 
Springer; 2018.
 5.  Freitas FL, Benzaken AS, Passos MR, Coelho IC, Miranda AE. 
Brazilian Protocol for Sexually Transmitted Infections 2020: 
acquired syphilis. Rev Soc Bras Med Trop. 2021;54 Suppl 
1:e2020616.
 6.  Correia C, Mendes R, Sanches M, Fernandes S, Soares-Almeida L, 
Borges-Costa J, et al. A unique presentation of papulonodular 
secondary syphilis in an elderly patient. Int J Dermatol, 
2021;60:e304-6.
 7.  Guillén BF, von der Weth MM, Oñate CV, Tapial JM, Bel PH. 
Secondary syphilis as a single annular plaque on the penis 
mimicking granuloma annulare. Indian J Dermatol Venereol 
Leprol. 2021;87:438.
 8.  O’Byrne P, Orser L, MacPherson P. Discussing current syphilis 
case definitions: a proposal for a “probable infectious” case. 
Public Health Nurs. 2021;38:390-5.
 9.  Centers for Disease Control and Prevention. Sexually transmitted 
diseases treatment guidelines, 2015. Atlanta: CDC; 2015.
 10.  Forrestel AK, Kovarik CL, Katz KA. Sexually acquired syphilis: 
laboratory diagnosis, management, and prevention. J Am Acad 
Dermatol. 2019;82:17-28.
 11.  Arando M, Mota-Foix M, Armegol P, Barberá MJ, Esperalba 
J, Vall-Mayans M. La evolución serológica en sífilis precoz. 
Enferm Infecc Microbiol Clin. 2019;37:183-6.
 12.  Geusau A, Kittler H, Hein U, Dangl-Erlach E, Stingl G, Tschachler 
E. Biological false-positive tests comprise a high proportion of 
venereal disease research laboratory reactions in an analysis 
of 300,000 sera. Int J STD AIDS. 2005;16:722-6.
 13.  Putri I, Mercer SE, Phelps RG, Levitt JO. False-negative anti-
treponemal immunohistochemistry in secondary syphilis. Int 
J Dermatol. 2013;52:172-6.
 14.  Castro R, Prieto ES, Santo I, Azevedo J, Exposto FL. Evaluation of 
an enzyme immunoassay technique for detection of antibodies 
against Treponema pallidum. J Clin Microbiol. 2003;41:250-3.
 15.  Seña AC, White BL, Sparling PF. Novel Treponema pallidum 
serologic tests: a paradigm shift in syphilis screening for the 
21st century. Clin Infect Dis. 2010;51:700-8.
 16.  Trayes KP, Savage K, Studdiford JS. Annular lesions: diagnosis 
and treatment. Am Fam Physician. 2018;98:283-91.
 17.  Bastos LM, Tolentino JM, Frota MA, Tomaz WC, Fialho ML, 
Batista AC, et al. Avaliação do nível de conhecimento em 
relação à Aids e sífilis por idosos do interior cearense, Brasil. 
Cien Saude Colet. 2018;23:2495-502.
